![]() |
||||||
|
![]() | |
![]() | |
![]() | Differntial gene expression between RNA A-to-I edited tumor samples versus normal samples |
![]() | |
![]() | |
![]() | The effects of the RNA editing to the stability of the RNA structures |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Editing gene: APOD (CAeditome ID:347) |
Gene summary for APOD |
![]() |
Gene information | Gene symbol | APOD | Gene ID | 347 |
Gene name | apolipoprotein D | |
Synonyms | - | |
Cytomap | 3q29 | |
Type of gene | protein-coding | |
Description | apolipoprotein Dapo-D | |
Modification date | 20210518 | |
UniProtAcc | P05090 | |
Context |
![]() |
Gene | GO ID | GO term | PubMed ID |
APOD | GO:0015485 | Apolipoprotein D | 9278274 |
APOD | GO:0000302 | Apolipoprotein D | 18419796 |
APOD | GO:0006006 | Apolipoprotein D | 19176353 |
APOD | GO:0006629 | Apolipoprotein D | 19176353 |
APOD | GO:0010642 | Apolipoprotein D | 14551159 |
APOD | GO:0042308 | Apolipoprotein D | 14551159 |
APOD | GO:0048662 | Apolipoprotein D | 14551159 |
APOD | GO:0060588 | Apolipoprotein D | 18419796 |
APOD | GO:0071638 | Apolipoprotein D | 18842892 |
APOD | GO:1900016 | Apolipoprotein D | 18842892 |
APOD | GO:2000405 | Apolipoprotein D | 18842892 |
APOD | GO:0005615 | Apolipoprotein D | 21705670 |
APOD | GO:0048471 | Apolipoprotein D | 14551159 |
Top |
RNA A-to-I events for APOD |
![]() |
![]() |
![]() |
![]() |
CAediting_336173(195582620, -), CAediting_336174(195582703, -), |
Top |
RNA editing positional annotations for APOD using Annovar |
![]() |
CAeditome ID | Position | Variant type | ENST | NTchange | AAchange | SIFT_score | Polyphen2_HVAR_score | PROVEAN_pred |
CAediting_336173 | chr3_195582620_- | nonsynonymous SNV | ENST00000421243.4 | c.A47G | p.Y16C | D | . | N |
![]() |
CAeditome ID | Position | Variant type |
CAediting_336173 | chr3_195582620_- | exonic |
CAediting_336174 | chr3_195582703_- | ncRNA_intronic |
![]() |
CAeditome ID | Position | Repeat family | Repeat sub family | Repeat name |
CAediting_336173 | chr3_195582620_- | SINE | Alu | AluSz |
CAediting_336174 | chr3_195582703_- | SINE | Alu | AluSz |
Top |
RNA A-to-I editing events in the alternative splicing sites for APOD |
![]() |
AStype | CAeditomID | Editing position | AS position | AS direction | Exonic location | Wildtype sequence | Wildtype splicing strength | RNA edited sequence | RNA edited splicing strength |
![]() |
![]() |
Top |
Differntial gene expression between RNA A-to-I edited versus non-edited samples for APOD |
![]() * The grey color means N/A. |
![]() |
![]() * Click on the image to enlarge it in a new window. |
Top |
Protein coding region RNA A-to-I editings for APOD |
![]() * Click on the image to enlarge it in a new window. |
Top |
The effects of the RNA editing to the miRNA binding sites for APOD |
**If you are searching a miRNA gene with RNA editing events in its seed regions, please see the search pages of miRNA targets to discover the effects of this RNA editing event to miRNA regulations. For more information, please check the files in the Download page. |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
CAediting_748296 | chr10_51299626_+ | ENSG00000189058.7 | ENST00000458447 | hsa-miR-605-3p | 195569080 | 195569086 | 7mer-m8 | 195569079 | 195569099 | 141 | -13.96 |
CAediting_980496 | chr14_31014685_- | ENSG00000189058.7 | ENST00000458447 | hsa-miR-624-3p | 195568765 | 195568771 | 7mer-m8 | 195568764 | 195568783 | 154 | -17.33 |
CAediting_1160181 | chr17_7017644_- | ENSG00000189058.7 | ENST00000458447 | hsa-miR-195-3p | 195568952 | 195568959 | 8mer-1a | 195568952 | 195568973 | 141 | -7.78 |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
Top |
The effects of the RNA editing to the stability of the RNA structures for APOD |
![]() * Click on the image to enlarge it in a new window. |
ENST | ENST type | RNA structure without RNA A-to-I editing. | RNA structure with RNA A-to-I editing. |
ENST00000421243.4 | protein_coding | ![]() | ![]() |
![]() |
CAeditom_ID | ENST | Editing_Position | MFE_withoneAI | MFE_withoutAI | MFE_withmultipleAI |
CAediting_336173 | ENST00000421243.4 | chr3_195582620_- | -214.00 | -213.70 | -216.10 |
CAediting_336174 | ENST00000421243.4 | chr3_195582703_- | -215.80 | -213.70 | -216.10 |
Top |
Relation with ADAR for APOD |
![]() |
Cancer | CAeditomID | position | ADAR1 (p-val) | ADAR1 (coeff.) | ADAR2 (p-val) | ADAR2 (coeff.) | ADAR3 (p-val) | ADAR3 (coeff.) |
Top |
Relation with cancer stages for APOD |
![]() |
Cancer | Stage_type | CAeditomID | position | P-val | Coeff. |
Top |
Relation with survival for APOD |
![]() |
Cancer | CAeditomID | position | KMpvalue | Coxpvalue | CoxHR |
Top |
RelatedDrugs for APOD |
![]() (DrugBank Version 5.1.8 2021-01-03) |
Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
APOD | P05090 | DB09130 | Copper | Apolipoprotein D | SmallMoleculeDrug | approved|investigational |
APOD | P05090 | DB00162 | Vitamin A | Apolipoprotein D | SmallMoleculeDrug | approved|nutraceutical|vet_approved |
Top |
RelatedDiseases for APOD |
![]() (DisGeNet 7.0) |
Gene | Disease ID | Disease name | # pubmeds | Source |
APOD | C0036341 | Schizophrenia | 3 | PSYGENET |
APOD | C0005586 | Bipolar Disorder | 1 | PSYGENET |
APOD | C0017638 | Glioma | 1 | CTD_human |
APOD | C0023186 | Learning Disorders | 1 | CTD_human |
APOD | C0086439 | Hypokinesia | 1 | CTD_human |
APOD | C0233565 | Bradykinesia | 1 | CTD_human |
APOD | C0242684 | Hypodynamia | 1 | CTD_human |
APOD | C0259783 | mixed gliomas | 1 | CTD_human |
APOD | C0270715 | Degenerative Diseases, Central Nervous System | 1 | CTD_human |
APOD | C0524851 | Neurodegenerative Disorders | 1 | CTD_human |
APOD | C0555198 | Malignant Glioma | 1 | CTD_human |
APOD | C0751262 | Adult Learning Disorders | 1 | CTD_human |
APOD | C0751263 | Learning Disturbance | 1 | CTD_human |
APOD | C0751265 | Learning Disabilities | 1 | CTD_human |
APOD | C0751701 | Hypokinesia, Antiorthostatic | 1 | CTD_human |
APOD | C0751733 | Degenerative Diseases, Spinal Cord | 1 | CTD_human |
APOD | C1330966 | Developmental Academic Disorder | 1 | CTD_human |